TaqPath™ COVID-19 Diagnostic PCR Kit
TaqPath™ COVID-19 Diagnostic PCR Kit
Applied Biosystems™

TaqPath™ COVID-19 Diagnostic PCR Kit

The Applied Biosystems TaqPath COVID-19 Diagnostic PCR Kit is a fast, highly sensitive multiplex diagnostic solution that contains the assaysRead more
Have Questions?
Catalog number A58505
Price (USD)/ Each
19,283.00
Add to cart
Quantity:
1000 reactions
Price (USD)/ Each
19,283.00
Add to cart
TaqPath™ COVID-19 Diagnostic PCR Kit
Catalog numberA58505
Price (USD)/ Each
19,283.00
-
Add to cart

The Applied Biosystems TaqPath COVID-19 Diagnostic PCR Kit is a fast, highly sensitive multiplex diagnostic solution that contains the assays and controls needed for the real-time PCR detection of RNA from the SARS-CoV-2 virus in nasopharyngeal and anterior nasal specimens.

Features of the TaqPath COVID-19 Diagnostic PCR Kit include:
Complete workflow—highly sensitive, specific, scalable solution for assessing 94 specimens using real-time PCR in as fast as 3 hours
Multi-target assay design—multiple gene targets for SARS-CoV-2 compensate for emerging mutations and variants, enabling increased confidence in results
Includes S gene target—may help with early identification of SARS-CoV-2 variants with S gene target failure (SGTF)

The TaqPath COVID-19 Diagnostic PCR Kit is compatible with the Applied Biosystems 7500 Fast Dx Real‐Time PCR Instrument and QuantStudio 5 Dx Real‐Time PCR Instrument. Results are analyzed and interpreted using COVID‐19 Interpretive Software IVD Edition.

Each kit includes the following components:
Multiplexed assays that contain three primer/probe sets specific to different SARS-CoV-2 genomic regions plus primers/probes for bacteriophage MS2
MS2 Phage Control as an internal process control for nucleic acid extraction
TaqPath COVID‐19 Diagnostic PCR Control as a positive RNA control that contains targets specific to the SARS-CoV-2 genomic regions targeted by the assays
TaqPath COVID‐19 Diagnostic PCR Control Dilution Buffer for use with the positive RNA control
Package insert provides instructions and link to download the instructions for use

Intended use
The TaqPath COVID-19 Diagnostic PCR Kit contains the assays and controls for a real-time reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal and anterior nasal specimens from symptomatic individuals suspected of COVID-19 by their healthcare provider.

Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper respiratory (anterior nasal and nasopharyngeal swabs) specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.

Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.

The TaqPath COVID-19 Diagnostic PCR Kit is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures.
 

For In Vitro Diagnostic Use. Not available in all countries or regions.
Specifications
CE MarkerNo
Clia ComplexityNot Applicable
Detectable AnalytesNucleic Acid
Detection MethodPrimer-probe
DoA CalibratorsNo
FormatCombo kit
Sample TypeSwab
SensitivityHigh
TypeRT-PCR Assay
For Use With (Application)Pathogen detection
No. of Reactions1000 Reactions
Quantity1000 reactions
FormLiquid
Unit SizeEach